Europe Platelet Rich Plasma (PRP) Market Expected to Reach USD 87.2 Million in 2022


Posted April 4, 2016 by ranutmr

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration.

 
A new Transparency Market Research report states that the Europe platelet rich plasma market stood at US$42.1 mn in 2013 and is predicted to reach US$ 87.2 mn in 2022. It is expected to expand at a CAGR of 8.30% from 2014 to 2022. The title of the report is, “Platelet Rich Plasma Market - Europe Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2022”.

only recently, platelet rich plasma therapy has been in use since the 1970s, when it was primarily used in dentistry.

Here’s how it works: A medical practitioner extracts an ounce or two of blood from an individual’s vein. The blood is then put into a centrifuge and spun so the platelets separate. The platelets are what secrete growth factors that allow blood to clot and the healing process to begin. The spun blood – which is now rich in plasma – is injected back into the individual’s body at the desired site where it helps expedite injured tissue repair.

With several success stories centered on the use of platelet rich plasma coming to the fore, consumers in Europe are expected to be more open to trying the therapy in a bid to fix orthopedic problems, for aesthetic procedures, and during neurosurgery. The Europe platelet rich plasma market was valued at US$42.1 mn in 2013, says market intelligence firm Transparency Market Research. This market is projected to stand at US$87.2 mn in 2022, registering an 8.3% CAGR between 2014 and 2022.

With Famous Sports Persons Endorsing the Therapy, Europe Platelet Rich Plasma Market Gains Immensely

The most celebrated sportspersons are constantly trying to outdo their best performance. But to do this, they’re also heavily reliant on the use of new treatments that can help them best their previous record – PRP is featuring prominently in the list of therapies that can help them meet this end.

With platelet-rich plasma being aggressively marketed as a cure-all for sports injuries, it’s not surprising that the treatment is becoming popular among sports persons – from Spanish tennis ace Rafael Nadal to American golfer Tiger Woods to American basketball player Kobe Bryant.

Driven by the proven success of platelet rich plasma in treating various orthopedic conditions, it isn’t surprising that in the Europe PRP market, the demand for the therapy in orthopedic applications was the highest. According to TMR, orthopedic procedures accounted for 38.3% of the Europe platelet rich plasma market in 2013.

Request Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4761

Use of Platelet Rich Plasma Therapy Accelerating in Cosmetic Procedures

Facials and other skin treatment procedures that use platelet rich plasma therapy as a base are drawing much attention in the skincare and cosmetic industry. Celebrities such as actor Kim Kardashian, who have undergone PRP therapy foe aesthetic reasons, have encouraged many others across the world to approach dermatologists for similar procedures.

A platelet rich plasma facial entails the extraction of blood from a person’s arm. The sample is then spun at high speeds in a machine to separate and concentrate the platelets. The plasma thus extracted is applied on a person’s face using extremely tiny needles – a procedure that doesn’t cause much pain or discomfort. Doctors say that this cosmetic procedure helps the skin build greater amounts of elastin and collagen to rejuvenate itself. The use of platelet rich plasma in cosmetic surgeries will thus help drive the Europe PRP market ahead.

Although there have been some reports that PRP hasn’t suited patients (Nadal, for one, said that he had to stop playing tennis for seven months the second time he took PRP as it didn’t work effectively), most patients typically report relief within a few weeks of undergoing PRP therapy. As more trials are conducted to improve the outcomes of platelet rich plasma therapy, the market will continue to surge ahead, not just in Europe but worldwide.

For More Information visit: http://www.tmrblog.com/2016/03/europe-platelet-rich-plasma-market.html


About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:

Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Marketing , Medical
Tags europe platelet rich plasma industry , platelet rich plasma market analysis , platelet rich plasma market forecasts , platelet rich plasma market in europe , platelet rich plasma market research report
Last Updated April 4, 2016